The recently launched UZH Life Sciences Fund, which is financed by the UZH Foundation and the Novartis Venture Fund with a total of CHF 20 million, aims to invest in spin-offs to accelerate the transfer of the their research findings into practice. The Fund has made its first investment of one million francs into CUTISS, a startup aiming to bring...